US Varicose Veins Treatment Market Research Report By Treatment Type (Sclerotherapy, Laser Therapy, Endovenous Laser Treatment, Radiofrequency Ablation, Surgical Ligation), By Procedure Type (Minimally Invasive, Surgical, Ambulatory), By End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Home Healthcare) and By Age Group (Adults, Elderly, Pediatric) - Forecast to 2035

US Varicose Veins Treatment Market Overview

As per MRFR analysis, the US Varicose Veins Treatment Market Size was estimated at 756 (USD Million) in 2023. The US Varicose Veins Treatment Market Industry is expected to grow from 832.1(USD Million) in 2024 to 1,338.5 (USD Million) by 2035. The US Varicose Veins Treatment Market CAGR (growth rate) is expected to be around 4.416% during the forecast period (2025 - 2035).

Key US Varicose Veins Treatment Market Trends Highlighted

The US Varicose Veins Treatment Market is seeing a notable shift toward minimally invasive procedures. These treatments, such as endovenous laser therapy (EVLT) and sclerotherapy, have gained popularity due to their shorter recovery times and reduced risk of complications compared to traditional surgical methods. Many patients prefer these options, leading to an increase in demand for such therapies.

Additionally, the rising awareness of cardiovascular health and the prevalence of varicose veins, often linked to obesity and sedentary lifestyles, is driving more individuals to seek treatment. Key market drivers include an aging population, as varicose veins are more common in older adults, and increased rates of obesity, which is a significant risk factor for developing venous disorders. The US healthcare system's focus on preventative care is also pushing patients to seek early intervention for varicose veins to avoid more severe complications in the future.

Opportunities to be explored include the integration of innovative technologies into treatment practices, such as ultrasound-guided techniques that enhance treatment precision. The expansion of outpatient facilities that provide these treatments can also improve patient access and convenience, contributing to the market's growth. Trends in recent times show that patient education and awareness campaigns are becoming more frequent, helping to demystify treatments and promote regular check-ups for venous diseases. Insurance coverage improvements for varicose vein treatments are also helping to increase patient access, indicating a shift toward a more supportive environment for individuals seeking these services. Overall, these elements are shaping a dynamic and growing landscape for varicose vein treatments in the US.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

US Varicose Veins Treatment Market Drivers

Increasing Incidence of Varicose Veins among Adults

The US Varicose Veins Treatment Market Industry is experiencing growth due to an increasing prevalence of varicose veins among adults. According to the National Institutes of Health, approximately 25% of women and 15% of men in the United States suffer from this condition, with numbers rising due to factors such as aging populations and sedentary lifestyles. The growing emphasis on diagnosis and treatment options has led to a rise in demand for effective treatments.

Organizations like the American Vein and Lymphatic Society are emphasizing education and awareness of venous diseases, thereby furthering the treatment market. With an expected significant increase in cases, healthcare providers are focusing on better managing and treating varicose veins, contributing to the market's projected growth in the coming years.

Advancements in Treatment Technologies

Technological innovations in varicose vein treatments like endovenous laser therapy have significantly improved patient outcomes, making them a vital driver in the US Varicose Veins Treatment Market Industry. Recent studies indicate that minimally invasive procedures result in quicker recovery times, with many patients returning to normal activities within a day. The American College of Phlebology reports that these advancements result in high success rates of over 90% in treated patients.

The persistent development of new technologies not only enhances patient satisfaction but also boosts the market as healthcare providers adopt these advanced solutions to offer better care.

Growing Awareness and Patient Education

The increasing awareness of varicose veins and available treatment options is significantly propelling the US Varicose Veins Treatment Market Industry. With campaigns from health organizations and healthcare professionals, more individuals are seeking diagnosis and treatment for their conditions. The American Vein and Lymphatic Society has increased efforts to educate the population, leading to higher patient engagement. Reports indicate that regions with established patient education programs see a growth in treatment seek rates by as much as 30%.

This growing awareness not only helps in early detection of varicose veins but also fosters a culture of proactive treatment, thus further energizing market growth.

Aging Population and Lifestyle Factors

The aging demographic in the US is a major contributor to the rise in varicose veins cases, significantly impacting the US Varicose Veins Treatment Market Industry. According to the U.S. Census Bureau, the number of adults aged 65 and older is projected to reach 95 million by 2060. As age is a key risk factor for varicose veins due to the weakening of vein walls and valve issues, this growing segment necessitates increased medical attention.

Furthermore, lifestyle factors such as obesity and prolonged sitting contribute to the development of varicose veins, indicating that the market will continue to thrive as these demographic and lifestyle changes persist. The healthcare sector responds by enhancing treatment options catered to this age group, creating a direct impact on market growth.

US Varicose Veins Treatment Market Segment Insights

Varicose Veins Treatment Market Treatment Type Insights

• The Treatment Type segment of the US Varicose Veins Treatment Market encompasses various approaches for managing and treating varicose veins, each playing a crucial role in addressing the needs of patients.


• Sclerotherapy, a commonly employed method, is recognized for its effectiveness in treating smaller veins and has gained popularity due to its minimally invasive nature and low recurrence rates.


• Laser Therapy is also becoming increasingly important, especially with advancements in technology leading to more precise treatment options, thus enhancing patient satisfaction and recovery times.

Endovenous Laser Treatment has emerged as a leading choice for patients with larger varicose veins because it offers numerous benefits such as less scarring and quicker recovery compared to traditional surgical methods, appealing to individuals seeking less invasive options. Radiofrequency Ablation continues to gain traction for its ability to effectively treat larger veins while ensuring minimal downtime, which is essential for patients looking to return to daily activities swiftly. Surgical Ligation remains a significant option for severe cases or those that have not responded to other treatments, providing a traditional surgical approach to effectively remove affected veins. Overall, the diversity of Treatment Types within the US Varicose Veins Treatment Market allows for tailored patient care, with each method contributing uniquely to the industry's landscape, addressing both clinical and patient preference dynamics. The choice of treatment often reflects broader trends in healthcare, including shifts towards minimally invasive procedures and patient-centered care, as more individuals seek efficient, effective solutions for managing varicose veins. The market continues to witness growth driven by technological advancements, increasing awareness of varicose vein conditions, and a growing elderly population who are more susceptible to this condition, all influencing the demand for effective treatment options within the US Varicose Veins Treatment Market.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Varicose Veins Treatment Market Procedure Type Insights

• The Procedure Type segment of the US Varicose Veins Treatment Market showcases diverse options reflective of technological advancements and patient preferences.


• The Minimally Invasive category has gained significant traction due to its advantages, including reduced recovery time and lower risk of complications, which align with the growing demand for outpatient procedures.


• Surgical interventions, while traditional, continue to hold importance among patients requiring more comprehensive treatment, often when minimally invasive procedures are insufficient.

Ambulatory techniques are also expanding, supporting the trend toward more convenient care settings, enhancing accessibility for patients. These distinct procedure types cater to various needs and present opportunities for healthcare providers to innovate, improving patient outcomes while navigating challenges related to insurance coverage and reimbursement policies. Overall, the US Varicose Veins Treatment Market segmentation by Procedure Type indicates a robust alignment with evolving healthcare trends, emphasizing the importance of delivering effective, patient-centered solutions.

Varicose Veins Treatment Market End User Insights

• The US Varicose Veins Treatment Market is significantly influenced by its End User segment, which encompasses various healthcare settings where treatment is administered.


• Hospitals play a crucial role, often equipped with advanced technologies and comprehensive care options, allowing them to accommodate complex cases.


• Ambulatory Surgical Centers are gaining traction due to their convenience and reduced overhead costs, appealing to patients seeking efficient treatment solutions.

Specialty Clinics provide focused expertise in vascular conditions, enhancing patient care and outcomes through tailored services. Home Healthcare is also becoming increasingly relevant, allowing for personalized treatment approaches, especially for patients preferring to receive care in the comfort of their homes. This multifaceted segmentation reflects the diverse healthcare landscape in the US, as providers adapt to patient needs and preferences while navigating regulatory challenges. Consequently, the market is poised for growth, driven by the increasing prevalence of varicose veins, changing demographics, and advancements in treatment technologies. Overall, the End User segment is crucial in shaping the delivery of varicose vein treatments in the US, indicating a robust landscape in the healthcare industry.

Varicose Veins Treatment Market Age Group Insights

• The Age Group segment of the US Varicose Veins Treatment Market reflects distinct dynamics critical to its growth trajectory.


• Adults represent a significant portion of the market, driven by lifestyle factors such as physical inactivity and obesity, which contribute to the prevalence of conditions leading to varicose veins.


• Meanwhile, the Elderly demographic is also a key player, as aging naturally increases the likelihood of such conditions due to weakened veins and decreased blood flow efficiency.

This group often seeks treatment due to the infusion of more health awareness and availability of advanced therapeutic options. Pediatric patients, while a smaller segment, showcase the importance of early intervention in vein-related issues that may develop due to genetic predispositions or other health conditions, emphasizing the necessity for continuous research and development. The differentiation in age groups highlights the varied approaches needed in treatment modalities and patient management. Market growth is fueled by an aging population, advances in medical technologies, and a broadened awareness of vascular health among all age groups. As a result, understanding the nuances of these segments becomes crucial for stakeholders aiming to tailor their offerings and improve patient outcomes in the US Varicose Veins Treatment Market.

US Varicose Veins Treatment Market Key Players and Competitive Insights

The competitive insights of the US Varicose Veins Treatment Market shed light on a sector characterized by rapid advancements and an increasing range of treatment options available for a condition that affects a significant portion of the population. This market is shaped by various factors including technological innovations, changing consumer preferences, and the need for more effective and minimally invasive treatment solutions. Key players are continually striving to enhance their products and services through research and development efforts that cater to both healthcare providers and patients, thus fostering a dynamic and competitive landscape. As more patients seek effective relief from symptoms associated with varicose veins, players in this market are expanding capabilities and product offerings to address the diversified needs of patients and clinicians alike.

Teleflex has established a strong market presence in the US Varicose Veins Treatment Market through its commitment to innovation and quality. The company is known for its range of medical devices and technologies that focus on enhancing patient outcomes while minimizing procedural complications. Within this specific market, Teleflex has developed various catheter-based solutions that cater to venous ailments, particularly in the treatment of varicose veins. The company's strengths lie in its advanced R&D capabilities, strategic collaborations with healthcare professionals, and a robust distribution network that ensures its products are widely accessible across clinical settings. This comprehensive approach allows Teleflex to solidify its reputation as a leading provider in the varicose veins treatment space, meeting a growing demand effectively.

Inari Medical's impact on the US Varicose Veins Treatment Market has been marked by its innovative approach to catheter technology and thrombectomy systems. The company primarily focuses on developing products that cater to venous thromboembolism, positioning itself to address both varicose veins and related conditions. With its flagship products offering minimally invasive treatment options, Inari Medical has rapidly gained traction in the US market. The company is known for its effective solutions that provide significant benefits to both physicians and patients. Additionally, Inari Medical has been proactive in pursuing strategic partnerships and potential mergers, further enhancing its market reach and product development capabilities. The combination of innovative technology, an expanding product portfolio, and a customer-oriented approach defines Inari Medical's strengths, enabling it to maintain a competitive edge within the US Varicose Veins Treatment Market.

Key Companies in the US Varicose Veins Treatment Market Include

• Teleflex


• Inari Medical


• Baylis Medical


• Medtronic


• Boston Scientific


• Abbott Laboratories


• Sapheon


• Vascular Solutions


• Cook Medical


• Lumenis


• AngioDynamics


• MediGain


• Bard Peripheral Vascular


• Dreampod

US Varicose Veins Treatment Market Industry Developments

The US Varicose Veins Treatment Market is witnessing significant developments with companies like Teleflex, Inari Medical, and Medtronic actively innovating and expanding their product offerings. In September 2023, Inari Medical launched a new device designed to improve patient outcomes in venous disease, further positioning itself as a leader in this niche. Boston Scientific has been enhancing its market presence through strategic partnerships aimed at advancing minimally invasive treatment options. The market has also seen an uptick in merger and acquisition activity; for instance, in August 2023, Teleflex announced its acquisition of a promising vascular technology company, which aims to leverage innovative treatment methodologies. 

Additionally, Abbott Laboratories has been investing in Research and Development initiatives focused on varicose vein management solutions, reflecting the increasing demand for effective treatments. The US market valuation continues to grow, influenced by rising awareness of varicose veins and their impact on overall health. This category is expected to experience further evolution with ongoing technological advancements and competitive strategies among key players, including Cook Medical and AngioDynamics, driving market dynamism over the next few years.

US Varicose Veins Treatment Market Segmentation Insights

Varicose Veins Treatment Market Treatment Type Outlook

• Sclerotherapy


• Laser Therapy


• Endovenous Laser Treatment


• Radiofrequency Ablation


• Surgical Ligation

Varicose Veins Treatment Market Procedure Type Outlook

• Minimally Invasive


• Surgical


• Ambulatory

Varicose Veins Treatment Market End User Outlook

• Hospitals


• Ambulatory Surgical Centers


• Specialty Clinics


• Home Healthcare

Varicose Veins Treatment Market Age Group Outlook

• Adults


• Elderly


• Pediatric

Report Attribute/Metric Source:	Details
MARKET SIZE 2018	756.0(USD Million)
MARKET SIZE 2024	832.1(USD Million)
MARKET SIZE 2035	1338.5(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR)	4.416% (2025 - 2035)
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR	2024
MARKET FORECAST PERIOD	2025 - 2035
HISTORICAL DATA	2019 - 2024
MARKET FORECAST UNITS	USD Million
KEY COMPANIES PROFILED	Teleflex, Inari Medical, Baylis Medical, Medtronic, Boston Scientific, Abbott Laboratories, Sapheon, Vascular Solutions, Cook Medical, Lumenis, AngioDynamics, MediGain, Bard Peripheral Vascular, Dreampod
SEGMENTS COVERED	Treatment Type, Procedure Type, End User, Age Group
KEY MARKET OPPORTUNITIES	Increasing geriatric population demand, Advancements in minimally invasive procedures, Growing awareness and education initiatives, Rising prevalence of obesity, Expanding aesthetic treatment options
KEY MARKET DYNAMICS	rising prevalence of varicose veins, increasing minimally invasive procedures, growing awareness of treatment options, aging population, advancements in treatment technologies
COUNTRIES COVERED	US